Genedrive Share Discussion Threads

[batiatus] 10/8/2024 17:59

Z1co and firestorm is the same person

They both spell thread as FRED and they both very aggressive in their language.

Anyway, who cares....

What's more important is getting out of this sinking ship.

And buying some GEX instead 🤪

[premium beeks] 10/8/2024 16:51

You're amazing.Wow

[premium beeks] 10/8/2024 16:30

Good to see you digging out the aliases btw, it's transparent and rather pathetic, but whatever makes you feel good about yourself eh.

[premium beeks] 10/8/2024 16:29

Wow, you are amazing. Like I say, I struggle to comprehend why you feel the need to be like you are on here, if you are so good at this game. It doesn't make sense. Unless you are lying of course. I mean, you certainly seem keen to tell us all how good you are. Why is that?

[premium beeks] 10/8/2024 16:03

Hmm, sure you did You never lose, do you. It's amazing how you still feel the need then to frequent these boards with your ramps and lies eh? Surely someone infallible doesn't need to resort to such low tactics?

[premium beeks] 10/8/2024 15:07

What's the correlation between my loss in CLCO and my (or anyone's) position here?None, none at all. I mean, we could listen to you with your purchase at 4.1p, but we won't.

[premium beeks] 10/8/2024 13:11

Why are you asking Z1co?He doesn't have a clue.

[eggbaconandbubble] 10/8/2024 13:09

Z1CO - "Looks like the new CEO is not going to be hanging about judging by his comments on SM:"

Can you explain please. I guess either not 'hanging about' re commercialisation or do mean as CEO of the company?

[premium beeks] 10/8/2024 12:31

What makes you think I'm EDL Z1co?Is everyone in Leeds EDL?

[batiatus] 10/8/2024 11:35

GDR is a flop.

GEX:

Next big thing is Helium.

Currently 15p with broker target £321 if they pull it off this December.

Https: //www.youtube.com/watch?v=uUhiPjkzLGI

[z1co] 10/8/2024 11:12

WISE UP OLD MAN BEEKS OF LEODIS ( LEEDS )

AND STOP THE SARCASTIC NONSENSE

We are all here to try to make some dough.

[premium beeks] 10/8/2024 11:00

Grow up Z1co.

[z1co] 10/8/2024 10:31

LOL

Beeks of Arabia >>>>>> to Premium Beeks

You changed your name from Beeks of Arabia to Premium Beeks back in November 2023 when you PAID ADVFN £10 TO BECOME PREMIUM USER SO THAT YOU COULD POST ON MY OBI THREAD.

You could only afford to pay advfn just one month fee and after that you've been a free user.

WELL I DON'T BLAME YOU AFTER LOSING ALL YOUR PENSION MONEY OF OVER £100,000 IN CLCO.

[premium beeks] 10/8/2024 10:13

I don't have any buddies. You seem to feel mated to anyone positive your holdings, everyone else is a troll or idiot. It's rinse and repeat across all your holdings - the exact reason you need to create a premium thread every time you take a position of course. Like I say, you'll temper for a while and then go back to your old ways. The evidence is all there to use at that time.

Anyway, won't turn this thread back in to you, will leave it at that.

[premium beeks] 10/8/2024 09:52

Thanks Z1co.Good to see you've tempered your comments. It won't last of course, you never learn. There was no reason to comment there of course. But you have to as is your want.Pushing the takeover narrative is just desperation. It's not been even hinted at and is just the mark of cretinous ramping.Re: up and down ticks. I'll take them more seriously when you stop using your 5 aliases to uptick yours. And let's face it, 2 of the downticks were yours and your slathering simping lapdog Hazl.

[z1co] 10/8/2024 07:06

Looks like the new CEO is not going to be hanging about judging by his comments on SM:


1d

💬 Gino Miele on his position as genedrive’s new CEO:

“Genotype-guided drug prescribing is gaining pace in clinical practice, and our company is at the forefront of this globally in clinical paradigms where test result availability to clinicians is time critical.

Our positioning in near-patient pharmacogenetic testing in emergency care paradigms is exemplified by our two leading products; our MT-RNR1 ID Kit for avoidance of antibiotic induced hearing loss in neonatal intensive care settings, and our CYP2C19 ID kit primarily aimed at pre-emptive stratification of those individuals presenting with stroke that are less likely to respond to the commonly prescribed antiplatelet Clopidogrel.

Both interventional products have been recognised & recommended by the UK National Institute for Clinical Care and Excellence for use in the UK NHS, offering significant potential monetary savings to healthcare systems and significantly better health outcomes for patients.

I’m thrilled to be leading the fantastic team at genedrive into our next phase of development; growth and commercialisation, and ultimately providing positive benefits to patients worldwide.”

His post yesterday:

Gino Miele, genedrive CEO said:

“The collaboration of our company with the research and clinical team at MFT is a shining example of the NHS collaborating with a commercial company, from early product development through to clinical validation in real-world settings, to deliver real improvements in patient outcomes in a cost-effective way. We are delighted with the positive recommendation from NICE and the success of the multi-disciplinary team collaboration under DEVOTE. We look forward to our CYP2C19 ID kit, the second point of care pharmacogenetic test developed in collaboration with this team for NHS use, being made available for the benefit of patients who have suffered a stroke or TIA.”